Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Abizol
- Development stage
- Unknown
- Lead developer
- Nobel İlaç
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Abizol is a branded version of aripiprazole, an atypical antipsychotic small molecule developed and marketed by Nobel Pharmaceuticals. It acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, while functioning as an antagonist at serotonin 5-HT2A receptors. This pharmacological profile allows it to modulate dopaminergic and serotonergic activity, making it effective for treating psychiatric conditions such as schizophrenia and manic episodes associated with bipolar disorder. Abizol is available in multiple oral strengths and an orally disintegrating tablet formulation known as Abizol EasyTab.
- Brand names
- AbizolAbizol EasyTab
- Other names
- aripiprazole
02
Targets
HTR2A (Serotonin receptor 5-HT2A)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))HTR2B (5-Hydroxytryptamine Receptor 2B)DRD2 (Dopamine D2 Receptor)DRD3 (Dopamine receptor D3)
Beyond the preview
Go deeper on Abizol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Abizol.